Anuncia Medical, Inc. recognized as an Arizona bioscience startup to watch in 2022 SCOTTSDALE, Ariz., March 30, 2022 /PRNewswire/ — Anuncia Medical, Inc., a medtech startup developing neurotherapeutic devices for treatment of hydrocephalus and other neurological disorders, has been selected as one of seven Arizona early-stage bioscience companies to participate in the 2022 Flinn Foundation Bioscience Entrepreneurship Program. A total of 54 […]
SkySong Innovation Center Bldg. #4
1355 N Scottsdale Rd, Suite 370
Scottsdale, Arizona 85257
The ReFlow Ventricular System is FDA cleared and CE Marked for use by a qualified clinician to facilitate a safe, noninvasive retrograde fluid flush when ventriculoperitoneal shunt flow is restricted or blocked. The ReFlow System Mini is under development and not available for sale. The ReFlow System is a prescription device sold by or on the order of a physician.
Trademark Legal Notice
All logos, and brands are property of their respective owners in the United States and/or other countries. All company, product and service names used on this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement.
Anuncia Inc. is not affiliated with or an official partner of MD&DI, Fast Company, and The FDA.